Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-86 - Occurrence of de Novo Dual HER2/HER3 or HER2/EGFR TMD Mutations: Extending the Spectrum of Targetable Mono-HER2 TMD in NSCLC?
09:45 - 09:45 | Presenter: Sai-Hong Ignatius Ou | Author(s): Alexa Betzig Schrock, Eduard V Bocharov, Jessica Lee, Russell Madison, Laurie Gay, Vincent A Miller, Brian Alexander, Hatim Husain, Jonathan Wesley Riess, Siraj M Ali, Vamsidhar Velcheti
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-25 - CT Based Vessel Tortuosity Features Are Prognostic of Overall Survival and Predictive of Immunotherapy Response in NSCLC Patients
09:45 - 09:45 | Presenter: Pranjal Vaidya | Author(s): Mehdi Alilou, Pradnya Dinkar Patil, Pingfu Fu, Kaustav Bera, Vamsidhar Velcheti, Anant Madabhushi
- Abstract
Loading...
-
+
P1.16 - Treatment in the Real World - Support, Survivorship, Systems Research
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
P1.16-15 - Rates of Systemic Anticancer Therapy (SACT) for Advanced Non-Small Cell Lung Cancer (aNSCLC) in the US, 2011–2018
09:45 - 09:45 | Presenter: Vamsidhar Velcheti | Author(s): Sheenu Chandwani, Xin Chen, Bilal Piperdi, Thomas Burke
- Abstract
Loading... -
+
P1.16-42 - Real-World Trends in Systemic Anticancer Therapy (SACT) for Squamous Advanced NSCLC (aNSCLC) in the US, 2011–2018
09:45 - 09:45 | Presenter: Vamsidhar Velcheti | Author(s): Sheenu Chandwani, Xin Chen, Bilal Piperdi, Thomas Burke
- Abstract
Loading...
-
+
PL02 - Presidential Symposium including Top 7 Rated Abstracts
- 08:00 - 10:15
- 9/09/2019
- Location: Barcelona (2005)
- IASLC CME Accredited
- Type: Plenary Session
- Track:
- Moderators:Giorgio Vittorio Scagliotti, Ramon Rami-Porta
-
+
PL02.08 - Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers
09:10 - 09:20 | Presenter: Alexander Drilon | Author(s): Geoffrey R Oxnard, Lori Wirth, Benjamin Besse, Oliver Gautschi, Shao Weng Daniel Tan, Herbert H. Loong, Todd Bauer, Yu Jung Kim, Atsushi Horiike, Keunchil Park, Manisha Shah, Caroline McCoach, Lyudmila Bazhenova, Takashi Seto, Marcia Brose, Nathan Pennell, Jared Weiss, Ignacio Matos, Nir Peled, Byoung Chul Cho, Yuichiro Ohe, Karen L Reckamp, Valentina Boni, Miyako Satouchi, Gerald S Falchook, Wallace Akerley, Haruko Daga, Tomohiro Sakamoto, Jyoti D Patel, Nehal Lakhani, Fabrice Barlesi, Mark Burkard, Viola W. Zhu, Victor Moreno, Jacques Medioni, Marc Matrana, Christian Rolfo, Dae Ho Lee, Hovav Nechushtan, Melissa Johnson, Vamsidhar Velcheti, Makoto Nishio, Ryo Toyozawa, Kadoaki Ohashi, Lucy Song, Ji-Youn Han, Alexander Spira, Filippo Guglielmo Maria De Braud, Kristoffer Staal Rohrberg, Shinji Takeuchi, Jun Sakakibara-Konishi, Saiama Waqar, Hirotsugu Kenmotsu, Frederick Wilson, Binoj Nair, Elizabeth Olek, Jennifer Kherani, Kevin Ebata, Edward Zhu, Michele Nguyen, Luxi Yang, Xin Huang, Scott Cruickshank, Stephen Michael Rothenberg, Benjamin J Solomon, Koichi Goto, Vivek Subbiah
- Abstract
Loading...
-
+
MA15 - Usage of Computer and Molecular Analysis in Treatment Selection and Disease Prognostication
- 15:45 - 17:15
- 9/09/2019
- Location: Tokyo (1982)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Pathology
- Moderators:John Le Quesne, Noriko Motoi
-
+
MA15.05 - Computerized Measurements of Cellular Diversity on H&E Tissue Are Prognostic of OS and Associated with Mutational Status in NSCLC
16:15 - 16:20 | Presenter: Vamsidhar Velcheti | Author(s): Cheng Lu, Kaustav Bera, Xiangxue Wang, Pingfu Fu, Michael Yang, David Rimm, Kurt A Schalper, Anant Madabhushi
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-16 - Novel CT Based Radiomic Features are Prognostic and Predictive of Benefit of Chemoimmunotherapy in Advanced Non-Squamous NSCLC
10:15 - 10:15 | Presenter: Kaustav Bera | Author(s): Pradnya Dinkar Patil, Mohammadhadi Khorrami, Alexia Zagouras, Pingfu Fu, Amit Gupta, Vamsidhar Velcheti, Nathan Pennell, Anant Madabhushi
- Abstract
Loading... -
+
P2.04-48 - Use of Immune Checkpoint Inhibitors in Patients with Advanced Lung Cancer and Pre-Existing Autoimmune Diseases
10:15 - 10:15 | Presenter: Samuel Cytryn | Author(s): Elizaveta Efuni, Vamsidhar Velcheti, Sabina Sandigursky
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P2.14-24 - An Open-Label Randomized Phase II Study of Combining Osimertinib With and Without Ramucirumab in TKI-Naïve EGFR-Mutant Metastatic NSCLC
10:15 - 10:15 | Presenter: Xiuning Le | Author(s): Viola W. Zhu, Andreas Saltos, Petros Nikolinakos, Kathryn F Mileham, Vamsidhar Velcheti, Hatim Husain, Monique Nilsson, Hai Tran, Emily Roarty, Edward Kim, Sai-Hong Ignatius Ou, Rachel E. Sanborn, Jhanelle Elaine Gray, Kwok-Kin Wong, Nasser Hanna, Vassiliki A Papadimitrakopoulou, John Victor Heymach
- Abstract
Loading...
-
+
P2.16 - Treatment in the Real World - Support, Survivorship, Systems Research
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
P2.16-17 - Real-World Trends in Systemic Therapy for Nonsquamous EGFR/ALK-Negative Advanced NSCLC (aNSCLC) in the US, 2011–2018
10:15 - 10:15 | Presenter: Vamsidhar Velcheti | Author(s): Sheenu Chandwani, Xin Chen, Bilal Piperdi, Thomas Burke
- Abstract
Loading... -
+
P2.16-41 - Pembrolizumab for Previously Treated, PD-L1–Expressing Advanced NSCLC: Real-World Time on Treatment and Overall Survival
10:15 - 10:15 | Presenter: Vamsidhar Velcheti | Author(s): Sheenu Chandwani, Xin Chen, Bilal Piperdi, Thomas Burke
- Abstract
Loading...
-
+
P2.17 - Treatment of Early Stage/Localized Disease
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Early Stage/Localized Disease
-
+
P2.17-34 - Integrated Clinico-Radiomic Nomogram for Predicting Disease-Free Survival (DFS) in Stage I and II Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Kaustav Bera | Author(s): Pranjal Vaidya, Priya Velu, Humberto Choi, Pingfu Fu, Amit Gupta, Vamsidhar Velcheti, Anant Madabhushi
- Abstract
Loading... -
+
P2.17-35 - Integrating CT Radiomic & Quantitative Histomorphometric Whole Slide Image Features Predicts Disease Free Survival in ES-NSCLC
10:15 - 10:15 | Presenter: Pranjal Vaidya | Author(s): Kaustav Bera, Xiangxue Wang, Pradnya Dinkar Patil, Vamsidhar Velcheti, Anant Madabhushi
- Abstract
Loading...
-
+
MA25 - Precision Medicine in Advanced NSCLC
- 14:30 - 16:00
- 9/10/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Sebastian Defranchi, Karen Kelly
-
+
MA25.02 - Arrangement and Architecture of Tumor-Infiltrating Lymphocyte on H&E Slides Predict OS in Nivolumab Treated Non-Small Cell Lung Cancer
14:37 - 14:44 | Presenter: Kaustav Bera | Author(s): Xiangxue Wang, Cristian Barrera, Cheng Lu, Michael Feldman, Kurt A Schalper, David Rimm, Vamsidhar Velcheti, Anant Madabhushi
- Abstract
Loading...